SIV-Specific Antibodies are Elicited by a Recombinant Fowlpox Virus Co-expressing SIV Gag and envT

Indian journal of microbiology(2018)

引用 1|浏览14
暂无评分
摘要
Given the failures of past HIV-1 vaccine clinical trials, potential HIV-1 vaccine candidates should be rigorously screened in preclinical models including simian immunodeficiency virus (SIV) primate models and small animal models. In this study, we tested the immunogenicity of a recombinant fowlpox virus (rFPV) expressing the SIV gag and SIV envT (rFPV sg–se ) proteins in BALB/c mice, to establish a foundation for further development. rFPV sg–se was constructed through homologous recombination techniques and purified through plaque screening assays using enhanced green fluorescent protein as the reporter gene. The integration, transcription, and translation of the SIV genes were measured by PCR (genomic DNA), RT-PCR (RNA), Western-blot, respectively. The levels of SIV-specific antibodies were assessed by ELISA following a single immunization (n = 18/group) or a prime-boost strategy (n = 24/group) with rFPV sg–se and compared to FPV and PBS controls. Residual virus was measured in distant organs following immunization using PCR. SIV-specific IgG titers against gag and gp120 were detected following single vaccination and the prime-boost. As expected the titers were higher following the prime-boost approach. The levels of Gag- and gp120-specific antibodies were significantly higher than controls ( p < 0.01) 14 days after the booster immunization. Residual rFPV Sg–Se was detected in the muscle at the site of injection, but not in distant organs, from day 1–7 post immunization. In summary, rFPV sg–se induced high levels of SIV-specific antibodies suggesting it may be a viable candidate for further development.
更多
查看译文
关键词
Recombinant fowlpox virus,SIV gag–envT,SIV-specific antibodies,Residual virus
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要